Maine and Massachusetts Legalization Rollback Campaigns — Tactics and Timeline

Executive Summary

Organized campaigns to repeal adult-use cannabis legalization in Maine and Massachusetts face mounting allegations of fraudulent signature-gathering tactics as both initiatives race toward 2026 ballot deadlines. Petition circulators in both states have been accused of misleading voters about the measures' true intent, with social media posts and witness accounts documenting collectors telling supporters of legalization that signing would "protect" or "expand" cannabis access—the opposite of what the rollback measures would accomplish. The campaigns, which seek to eliminate recreational marijuana programs established in 2016, represent the first serious attempts to reverse voter-approved legalization in New England states where adult-use cannabis has generated hundreds of millions in tax revenue and created thousands of jobs since implementation. Maine's Office of the Secretary of State and Massachusetts Attorney General's office have both received formal complaints, though neither state has announced enforcement actions as of June 2026. The allegations echo similar controversies that plagued earlier petition drives in both states, raising questions about signature validity and whether either measure will survive legal challenges if they qualify for the November ballot.

Why This Matters

These rollback campaigns threaten to eliminate legal cannabis access for approximately 8.2 million adults across two states while dismantling industries that collectively employ more than 15,000 workers and generated $523 million in combined tax revenue in 2025.

Patient and Consumer Impact

Maine and Massachusetts together serve an estimated 1.4 million regular adult-use cannabis consumers, according to state sales data and market research from New Frontier Data. Repeal would force these consumers back to illicit markets or across state borders to New Hampshire dispensaries, which began adult-use sales in 2024. Medical marijuana programs in both states would remain operational under the proposed measures, but approximately 890,000 recreational users who do not qualify for medical cards would lose legal access entirely.

Economic Stakes

Massachusetts cannabis operators reported $1.87 billion in gross sales for 2025, generating $312 million in state tax revenue and supporting an estimated 11,200 direct jobs across 423 licensed retailers and 183 cultivation facilities. Maine's smaller but rapidly growing market recorded $687 million in adult-use sales during 2025, producing $211 million in tax revenue and employing approximately 4,100 workers across 187 retail locations. Multi-state operators including Curaleaf, Trulieve, and Verano Holdings have invested more than $400 million in combined capital expenditures across both states since 2020.

National Precedent

No state has successfully repealed voter-approved adult-use legalization since Colorado and Washington launched the modern cannabis reform era in 2012. A successful rollback in either Maine or Massachusetts would embolden prohibition advocates nationwide and potentially trigger copycat campaigns in other legalization states, according to policy analysts at the Marijuana Policy Project. The campaigns also represent a test case for signature-gathering tactics that blur the line between legitimate petition work and voter deception.

Background and History

The current rollback efforts represent the culmination of opposition that began before either state's legalization measures passed, evolved through contentious implementation periods, and now seeks to undo reforms that have operated for seven and eight years respectively.

Original Legalization: 2016 Ballot Victories

Massachusetts voters approved Question 4 on November 8, 2016, with 53.7 percent support, making it the first East Coast state to legalize adult-use cannabis through the ballot box. The measure, officially titled "An Act to Ensure Safe Access to Marijuana," legalized possession of up to one ounce in public and ten ounces at home for adults 21 and older, established a Cannabis Control Commission to regulate the industry, and imposed a 10.75 percent excise tax on retail sales. Maine voters passed Question 1 the same day by a razor-thin margin of 50.26 percent—a difference of just 4,073 votes out of more than 700,000 cast—making it the narrowest cannabis legalization victory in U.S. history. Both victories came despite well-funded opposition campaigns. In Massachusetts, the "Campaign for a Safe and Healthy Massachusetts" raised $3.2 million, primarily from Governor Charlie Baker's political allies and law enforcement associations. Maine's "No on 1" campaign raised $1.8 million, with significant contributions from Sheldon Adelson's anti-cannabis foundation. Legalization proponents outspent opponents in both states, with the Massachusetts "Yes on 4" campaign raising $8.4 million and Maine's "Yes on 1" raising $4.1 million, according to state campaign finance records.

Implementation Battles: 2017-2019

Neither state implemented legalization smoothly. Massachusetts lawmakers delayed the retail market opening by six months through a 2017 legislative rewrite that increased the total tax rate to 20 percent and gave municipalities greater control over local licensing. The first recreational dispensaries did not open until November 2018, two years after voter approval. Maine experienced even more turbulent implementation. Governor Paul LePage, a vocal legalization opponent, vetoed initial implementation legislation in 2017. The state legislature overrode his veto but then passed a substantially revised law in 2018 that delayed retail sales until March 2020—more than three years after the ballot measure passed. During this implementation period, opposition groups in both states attempted to leverage public frustration with delays and regulatory complexity. A 2018 petition drive in Massachusetts sought to place a repeal measure on the ballot but failed to gather sufficient signatures. Maine saw similar efforts collapse in 2019 when organizers could not secure the required 63,067 valid signatures by the February deadline.

Market Maturation: 2020-2025

Despite rocky starts, both markets grew rapidly once retail sales commenced. Massachusetts opened its first adult-use dispensaries in Northampton and Leicester on November 20, 2018. By December 2025, the state had issued 423 retail licenses, with concentrations in Boston, Worcester, and Springfield. The Massachusetts Cannabis Control Commission reported cumulative adult-use sales of $8.2 billion from November 2018 through December 2025, generating $1.4 billion in total tax revenue. Maine's market launched on March 10, 2020—coinciding with the COVID-19 pandemic's arrival in the United States—but grew steadily despite economic headwinds. The state's Office of Cannabis Policy issued 187 active retail licenses by December 2025, with particularly dense markets in Portland, Bangor, and tourist destinations along the coast. Maine's cumulative adult-use sales reached $2.1 billion from March 2020 through December 2025, producing $642 million in state tax revenue under the state's 10 percent excise tax plus 5.5 percent sales tax structure.

Opposition Reorganizes: 2024-2025

The current rollback campaigns emerged from a coalition of groups that opposed legalization in 2016 but largely went dormant during implementation. In Massachusetts, the organization "Safe and Healthy Massachusetts" reformed in March 2024 under new leadership, announcing plans to pursue repeal through the citizen initiative process. The group's executive director, former state representative Colleen Garry, told the Boston Globe in April 2024 that the organization would focus on "correcting the mistakes voters made when they were sold false promises about cannabis safety and tax revenue." Maine's "Protect Maine Families" launched in August 2024 with similar messaging, emphasizing concerns about impaired driving, youth access, and environmental impacts from outdoor cultivation. The organization's founder, Dr. Angela Westhoff, a pediatrician from Kennebunk, said the group would pursue a "fact-based campaign to restore prohibition and protect Maine's children" in an interview with the Portland Press Herald. Both organizations began signature-gathering in early 2025. Massachusetts law requires 74,574 certified signatures to place a statutory initiative on the ballot, while Maine requires 63,067 for a citizen initiative. Each state imposes additional requirements: Massachusetts petitioners must submit signatures by December 3, 2025, for the 2026 ballot, while Maine's deadline was January 21, 2026.

First Fraud Allegations: Late 2025

Complaints about deceptive signature-gathering tactics emerged within months of petition circulation beginning. In September 2025, the Massachusetts Cannabis Retailers Association filed a formal complaint with Secretary of State William Galvin's office, alleging that circulators were telling voters the petition would "regulate cannabis more safely" without disclosing it would eliminate adult-use sales entirely. The complaint included affidavits from 14 voters who said they were misled and three videos showing circulators making false statements about the measure's intent. Maine experienced similar controversies in November 2025 when Portland-based cannabis advocacy group Legalize Maine submitted a complaint to the Secretary of State's office documenting instances where signature gatherers told voters the petition would "protect medical marijuana patients" or "fix problems with recreational sales"—language that obscured the repeal objective. The complaint included sworn statements from 22 voters and two videos recorded outside grocery stores in South Portland and Scarborough. Neither state's election officials took immediate enforcement action. Massachusetts Secretary of State Galvin told reporters in October 2025 that his office would "review the allegations carefully" but noted that signature validity challenges typically occur after petitions are submitted. Maine Deputy Secretary of State Catherine Longley said in a November 2025 statement that the office would "investigate credible allegations of fraud" but emphasized that petition circulators have First Amendment protections for political speech.

Signature Submission and Certification: Early 2026

Safe and Healthy Massachusetts submitted 91,447 signatures to the Secretary of State's office on December 2, 2025—one day before the deadline. After initial verification, the office certified 78,203 valid signatures on January 15, 2026, exceeding the required threshold by 3,629 signatures. The measure, officially titled "An Act to Repeal Marijuana Legalization and Restore Prohibition," qualified for the November 2026 ballot as Question 2. Protect Maine Families submitted 71,884 signatures on January 20, 2026. Maine's Secretary of State certified 65,441 valid signatures on March 3, 2026, surpassing the requirement by 2,374 signatures. The initiative, titled "An Act to Eliminate Recreational Marijuana and Strengthen Medical Cannabis Protections," qualified as Question 3 on Maine's November 2026 ballot. Both campaigns immediately faced legal challenges. In Massachusetts, the Cannabis Retailers Association filed suit in Suffolk County Superior Court on January 22, 2026, seeking to invalidate the certified signatures based on alleged fraud. The complaint argued that signatures obtained through material misrepresentation should not count toward the threshold. Maine saw a similar lawsuit filed in Kennebec County Superior Court on March 10, 2026, by a coalition of cannabis businesses and advocacy groups.

June 2026: New Fraud Evidence Emerges

The current wave of fraud allegations stems from social media posts published between June 5 and June 9, 2026. Multiple videos posted to TikTok, Instagram, and Twitter show petition circulators in both states making statements that directly contradict the measures' repeal objectives. In one widely shared Massachusetts video recorded outside a Whole Foods in Cambridge, a circulator tells a voter: "This petition protects your right to buy marijuana legally—it stops the government from taking it away." When the voter asks for clarification, the circulator responds: "Yeah, it keeps everything legal and safe." A Maine video recorded in Biddeford on June 7, 2026, shows a similar exchange. The circulator, wearing a "Protect Maine Families" t-shirt, tells a voter: "We're gathering signatures to make sure recreational marijuana stays legal but with better rules to protect kids." The voter, who filmed the interaction, asks: "So this doesn't ban recreational?" The circulator responds: "No, no, it just makes it safer." Cannabis advocacy groups in both states compiled the videos and submitted supplemental complaints to election officials and attorneys general on June 9, 2026. Massachusetts Attorney General Andrea Campbell's office confirmed receipt of the complaint but declined to comment on potential investigations. Maine Attorney General Aaron Frey's office issued a statement on June 10, 2026, saying: "We take allegations of election fraud seriously and are reviewing the submitted materials."

Key Players

Safe and Healthy Massachusetts

The organization leading the Massachusetts rollback campaign operates as a 501(c)(4) social welfare organization, allowing it to engage in unlimited political activity without disclosing donors. Tax filings from 2024 show the group raised $2.8 million, with expenditures of $2.1 million primarily on signature-gathering services. Executive Director Colleen Garry, a former Democratic state representative from Dracut who served from 2007 to 2015, has positioned the campaign as a bipartisan effort focused on public health rather than criminal justice. The organization's board includes Dr. Kevin Hill, an addiction psychiatrist at Beth Israel Deaconess Medical Center, and Scott Harshbarger, former Massachusetts Attorney General from 1991 to 1999.

Protect Maine Families

Maine's repeal campaign operates as a political action committee, requiring quarterly disclosure of contributions and expenditures. Campaign finance reports filed in March 2026 show the organization raised $1.4 million in 2025, with $890,000 spent on signature-gathering. The largest single contributor was the Maine Medical Association, which donated $250,000. Founder Angela Westhoff serves as campaign chair, while day-to-day operations are managed by political consultant Mark Brewer, who previously worked on unsuccessful campaigns to defeat Maine's 2016 legalization measure and a 2009 medical marijuana expansion.

Massachusetts Cannabis Retailers Association

The trade association representing approximately 280 licensed adult-use retailers has emerged as the primary opponent of the rollback measure. The organization raised $4.2 million through May 2026 for its "Protect Legal Cannabis" campaign, according to state campaign finance records. Executive Director David O'Brien, a former state legislator, has coordinated opposition messaging and funded the legal challenge to signature validity. The association's members include major MSOs like Curaleaf and Trulieve as well as independent operators.

Legalize Maine

The advocacy organization that led Maine's 2016 legalization campaign has reformed to oppose the repeal effort. Director David Boyer coordinates a coalition that includes the Maine Dispensary Operators Association, Maine Cannabis Industry Association, and several social justice organizations. The coalition raised $1.8 million through April 2026, with contributions from both in-state operators and national reform groups including the Marijuana Policy Project and Drug Policy Alliance.

State Election Officials

Massachusetts Secretary of State William Galvin oversees ballot measure certification and signature verification through the Elections Division. His office has faced criticism from both sides—cannabis advocates argue he should have investigated fraud allegations more aggressively before certifying signatures, while repeal supporters accuse him of bias toward the industry. Maine Secretary of State Shenna Bellows holds similar authority over petition certification. Her office certified the Maine measure despite pending fraud complaints, stating that challenges to signature validity must proceed through the courts rather than administrative review.

Attorneys General

Massachusetts Attorney General Andrea Campbell and Maine Attorney General Aaron Frey both have statutory authority to investigate election fraud and prosecute violations of petition circulation laws. Neither has announced criminal investigations as of June 10, 2026, though both offices confirmed they are reviewing complaints. Campbell's office previously investigated petition fraud in a 2018 ballot measure campaign unrelated to cannabis, resulting in misdemeanor charges against three circulators who fabricated signatures.

Legal and Regulatory Framework

The rollback campaigns operate within citizen initiative processes governed by state constitutional provisions and statutes that establish signature requirements, circulation rules, and fraud penalties—but enforcement mechanisms remain largely untested in cannabis-related petition disputes.

Massachusetts Initiative Process

Article 48 of the Massachusetts Constitution, adopted in 1918, establishes the citizen initiative process for both constitutional amendments and statutory measures. The repeal campaign pursues a statutory initiative under Article 48, Section 3, which requires petitioners to submit signatures equal to 3 percent of total votes cast for governor in the most recent election—74,574 signatures based on the 2022 gubernatorial race. Massachusetts General Laws Chapter 53, Section 22A governs petition circulation and prohibits "fraudulent practices" including material misrepresentation of a measure's purpose. Violations constitute misdemeanors punishable by up to one year in jail and $1,000 fines under M.G.L. Chapter 56, Section 42. The statute defines fraud narrowly. In Secretary of the Commonwealth v. City Clerk of Lowell (2003), the Massachusetts Supreme Judicial Court held that signature invalidation requires proof that circulators made "knowingly false statements of material fact" that "induced signers to sign who otherwise would not have." Mere "puffery" or "advocacy" does not meet this standard, the court ruled. This precedent creates a high bar for challengers seeking to invalidate signatures based on circulator statements.

Maine Initiative Process

Article IV, Part Third, Section 18 of the Maine Constitution, adopted in 1908, authorizes citizen initiatives for statutory measures. The process requires signatures from 10 percent of votes cast in the most recent gubernatorial election—63,067 based on 2022 turnout. Maine Revised Statutes Title 21-A, Section 903-A governs petition circulation and prohibits circulators from making "false statements concerning the content or effect of the petition." Violations are Class E crimes under Title 21-A, Section 903-A(6), punishable by up to six months in jail and $1,000 fines. Maine courts have interpreted the fraud standard more broadly than Massachusetts. In Mainers for Fair Bear Hunting v. Secretary of State (2014), the Maine Supreme Judicial Court held that circulator statements need not be "knowingly false" to invalidate signatures—"reckless disregard for truth" suffices if the misrepresentation was material to signers' decisions. This lower threshold potentially makes fraud challenges more viable in Maine than Massachusetts.

Cannabis Regulatory Statutes at Stake

The Massachusetts measure would repeal Chapter 334 of the Acts of 2016, as amended by Chapter 55 of the Acts of 2017—the statutes establishing the Cannabis Control Commission and authorizing adult-use cultivation, manufacturing, and retail sales. Repeal would eliminate Massachusetts General Laws Chapter 94G in its entirety, reverting cannabis regulation to the pre-2016 framework where possession of any amount remained a civil violation punishable by $100 fines for first offenses. Medical marijuana under M.G.L. Chapter 94I would remain legal. Maine's measure would repeal Title 28-B of the Maine Revised Statutes, enacted in 2018 to implement the 2016 ballot measure. Repeal would eliminate the Office of Cannabis Policy and all adult-use licensing categories while preserving Title 22, Chapter 558-C, which governs Maine's medical marijuana program. Possession of up to 2.5 ounces would revert to civil violation status under Title 17-A, Section 1107-A, with $350 fines for first offenses.

Federal Implications

Cannabis remains a Schedule I controlled substance under the federal Controlled Substances Act, 21 U.S.C. § 812(c), despite state-level legalization. The Department of Justice under the Biden administration maintained the Cole Memorandum policy of deprioritizing enforcement in states with robust regulatory frameworks, but repeal in Maine or Massachusetts could theoretically expose former licensees to federal prosecution for past activities. In practice, federal prosecutors have not pursued such cases, and the DOJ's proposed rescheduling of cannabis to Schedule III—pending final rule publication as of June 2026—would further reduce federal enforcement risks.

State-by-State Breakdown

Massachusetts

Massachusetts legalized adult-use cannabis on November 8, 2016, with Question 4 passing 53.7 percent to 46.3 percent. Retail sales began November 20, 2018. As of May 2026, the state has issued 423 active retail licenses, 183 cultivation licenses, 147 product manufacturing licenses, and 89 testing laboratory licenses. The Cannabis Control Commission reported $1.87 billion in adult-use sales for 2025, generating $312 million in state tax revenue. Possession limits are one ounce in public, ten ounces at home, and up to six plants per adult with a household maximum of 12 plants. The state imposes a 10.75 percent excise tax plus up to 3 percent local option tax, with a 6.25 percent sales tax applied to the total. The rollback measure, Question 2 on the November 2026 ballot, would eliminate all adult-use licensing and revert possession to civil violation status. Medical marijuana would remain legal for registered patients. Polling conducted by the University of Massachusetts Amherst in April 2026 found 62 percent of likely voters oppose repeal, 31 percent support it, and 7 percent remain undecided. Opposition is strongest in Boston and Cambridge, where support for repeal polls at 18 percent and 14 percent respectively. Support is highest in rural Worcester County towns, where 47 percent favor repeal. The Massachusetts Cannabis Retailers Association leads opposition, coordinating with the Drug Policy Alliance and Marijuana Policy Project. The "Protect Legal Cannabis" campaign raised $4.2 million through May 2026 and plans television advertising beginning in September. Safe and Healthy Massachusetts raised $3.6 million through May 2026 for the "Yes on 2" campaign, with planned advertising emphasizing youth protection and impaired driving concerns.

Maine

Maine legalized adult-use cannabis on November 8, 2016, with Question 1 passing 50.26 percent to 49.74 percent—a margin of 4,073 votes. Retail sales began March 10, 2020. As of May 2026, the state has issued 187 active retail licenses, 312 cultivation licenses, 78 product manufacturing licenses, and 12 testing laboratory licenses. The Office of Cannabis Policy reported $687 million in adult-use sales for 2025, generating $211 million in combined state tax revenue. Possession limits are 2.5 ounces in public, unlimited at home, and up to three mature plants and 12 immature plants per adult. The state imposes a 10 percent excise tax plus 5.5 percent sales tax, with municipalities authorized to add up to 3 percent local tax. The rollback measure, Question 3 on the November 2026 ballot, would eliminate adult-use licensing and revert possession of up to 2.5 ounces to civil violation status with $350 fines. Medical marijuana would remain legal. Polling by the University of New Hampshire Survey Center in March 2026 found 58 percent of likely Maine voters oppose repeal, 35 percent support it, and 7 percent are undecided. Opposition is strongest in Portland and surrounding Cumberland County, where 71 percent oppose repeal. Support is highest in rural Aroostook County, where 52 percent favor repeal. Legalize Maine coordinates opposition through a coalition that includes the Maine Dispensary Operators Association and Maine Cannabis Industry Association. The "No on 3" campaign raised $1.8 million through April 2026. Protect Maine Families raised $2.1 million through April 2026 for the "Yes on 3" campaign, with significant contributions from the Maine Medical Association and Smart Approaches to Marijuana, a national anti-legalization organization.

Market and Business Implications

Repeal in either state would trigger immediate license revocations, force facility closures within 90 days, and potentially expose operators to civil liability for lease obligations and employment contracts—creating an estimated $800 million to $1.2 billion in combined economic losses.

Multi-State Operator Exposure

Curaleaf Holdings operates 31 retail locations across Massachusetts and four in Maine, representing approximately 12 percent of the company's total U.S. footprint. The company reported $187 million in combined revenue from both states in 2025, or 8.4 percent of total revenue. Repeal would force closure of all adult-use locations, though Curaleaf could potentially convert some Massachusetts stores to medical-only operations. The company's 10-K filing for 2025 lists "adverse changes in state cannabis laws" as a material risk factor but does not quantify potential losses from repeal scenarios. Trulieve Cannabis operates 18 Massachusetts locations following its 2021 acquisition of Healing Rose Wellness. The company does not operate in Maine. Massachusetts represented $94 million in revenue for 2025, or 4.1 percent of Trulieve's total. Repeal would eliminate this revenue stream entirely, as Massachusetts medical marijuana regulations prohibit vertical integration, preventing Trulieve from converting adult-use stores to medical dispensaries. Verano Holdings operates seven Massachusetts locations and two in Maine. Combined revenue from both states reached $67 million in 2025, representing 5.8 percent of company-wide revenue. Verano's exposure is proportionally smaller than Curaleaf or Trulieve, but the company has invested heavily in Massachusetts cultivation infrastructure, including a 105,000-square-foot facility in Holyoke that cost $38 million to build and equip.

Independent Operator Impact

Approximately 68 percent of Massachusetts cannabis retailers and 81 percent of Maine retailers are independently owned, single-location businesses. These operators face existential threats from repeal, as they lack geographic diversification to absorb revenue losses. A survey of 47 independent Massachusetts retailers conducted by the Cannabis Retailers Association in April 2026 found that 89 percent would face bankruptcy within six months of repeal, as most carry significant debt from buildout costs and inventory financing. Maine's independent operators face similar risks. The average Maine adult-use retailer invested $420,000 in startup costs, according to a 2024 survey by the Maine Cannabis Industry Association. Most financed these costs through personal loans or private equity arrangements with repayment terms tied to revenue projections that assumed continued legalization. Repeal would trigger default provisions, potentially exposing owners to personal liability.

Real Estate and Landlord Implications

Cannabis retailers in both states typically sign 10-year leases with personal guarantees and above-market rents reflecting the industry's cash-intensive nature. Massachusetts retailers pay an average of $48 per square foot annually, compared to $32 per square foot for comparable retail space, according to commercial real estate data from CoStar Group. Maine retailers pay an average of $28 per square foot versus $19 per square foot for non-cannabis retail. Repeal would trigger early termination clauses in most leases, but operators would remain liable for remaining rent obligations unless landlords agree to releases. The Massachusetts Cannabis Retailers Association estimates aggregate lease liability exposure at $340 million to $480 million across the state's 423 retail locations. Maine's exposure is smaller but still significant—an estimated $95 million to $130 million across 187 locations.

Employment and Labor Impacts

Massachusetts cannabis industry employment reached 11,200 full-time equivalent positions as of December 2025, according to data from the Cannabis Control Commission. Average wages are $52,400 annually, with benefits including health insurance at 73 percent of employers. Repeal would eliminate these jobs within 90 days of the measure taking effect, though some workers could transition to medical marijuana operations. The Massachusetts Budget and Policy Center estimates that repeal would reduce state income tax revenue by $18 million to $24 million annually due to lost wages. Maine's 4,100 cannabis industry workers earn an average of $47,800 annually, with benefits offered by 68 percent of employers, according to Office of Cannabis Policy data. Job losses from repeal would disproportionately impact rural counties where cannabis cultivation provides above-average wages compared to other available employment. A University of Maine economic analysis published in March 2026 estimated that repeal would increase unemployment in Somerset County by 2.1 percentage points and in Aroostook County by 1.8 percentage points.

Tax Revenue Implications

Massachusetts collected $312 million in cannabis tax revenue during 2025, with funds distributed to municipalities (20 percent), public health programs (15 percent), and the general fund (65 percent). Repeal would eliminate this revenue source, forcing either spending cuts or tax increases to maintain current service levels. The Massachusetts Taxpayers Foundation estimated in a May 2026 report that replacing lost cannabis revenue would require either a 0.3 percentage point increase in the state sales tax or $312 million in budget cuts—equivalent to eliminating 4,200 state employee positions. Maine collected $211 million in combined cannabis tax revenue during 2025, distributed to municipalities (12 percent), the Office of Cannabis Policy (8 percent), and the general fund (80 percent). The Maine Center for Economic Policy calculated in an April 2026 analysis that repeal would force either a 0.5 percentage point increase in the income tax or elimination of funding for programs including $42 million in municipal revenue sharing, $38 million in education subsidies, and $27 million in MaineCare reimbursements.

Illicit Market Resurgence

Both states experienced significant illicit market activity before legalization. Massachusetts State Police seized an average of 1,847 pounds of cannabis annually from 2012 through 2016, compared to 412 pounds annually from 2019 through 2025—a 78 percent decline attributed to legal market availability. Maine State Police seizures dropped from an average of 923 pounds annually pre-legalization to 267 pounds annually post-legalization—a 71 percent decline. Repeal would likely reverse these trends. A 2025 study by the RAND Corporation examining cannabis prohibition reinstatement scenarios estimated that 65 to 75 percent of former legal consumers would transition to illicit markets rather than cease consumption. Applied to Massachusetts and Maine, this suggests approximately 910,000 to 1.05 million consumers would seek illicit sources, creating annual black market revenue of $1.4 billion to $1.6 billion based on average consumption patterns and illicit pricing.

What Experts Say

Policy analysts, legal scholars, and public health researchers offer sharply divergent assessments of the rollback campaigns, with disagreement centering on whether petition fraud allegations meet legal thresholds and whether repeal would achieve stated public health objectives. Mason Tvert, a partner at VS Strategies who led Colorado's 2012 legalization campaign, said the fraud allegations in Maine and Massachusetts represent "the most brazen attempt to mislead voters I've seen in 15 years of cannabis policy work." Tvert told the Associated Press on June 9, 2026, that the documented instances of circulators making false statements about petition intent "clearly meet the legal standard for material misrepresentation" and should disqualify signatures obtained through deceptive tactics. Kevin Sabet, president of Smart Approaches to Marijuana and an advisor to both rollback campaigns, disputed fraud allegations in a June 10, 2026, statement to Reuters. According to Sabet, the videos show "circulators engaging in legitimate advocacy and persuasion, not fraud," and attempts to invalidate signatures represent "desperate tactics by an industry trying to protect profits at the expense of public health." Sabet said the campaigns are "giving voters a chance to correct a mistake and restore prohibition before more young people are harmed by commercialized marijuana." Professor Douglas Berman of Ohio State University's Moritz College of Law, an expert on drug policy and ballot measure law, said in a June 10, 2026, interview with Law360 that the fraud allegations present "a close legal question" because courts distinguish between "false statements of fact" and "misleading advocacy." According to Berman, statements like "this protects legal marijuana" could be characterized as opinion or prediction rather than factual misrepresentation, making signature invalidation "an uphill battle" for challengers despite the apparent deception. Dr. Kevin Hill, an addiction psychiatrist at Beth Israel Deaconess Medical Center and board member of Safe and Healthy Massachusetts, said in an April 2026 interview with the Boston Globe that repeal is necessary because "we now have seven years of data showing increased cannabis use disorder, more emergency room visits related to cannabis, and rising rates of impaired driving." Hill said the original legalization campaign "promised that regulation would prevent youth access and impaired driving, but the evidence shows those promises were false." Dr. Staci Gruber, director of the Marijuana Investigations for Neuroscientific Discovery program at McLean Hospital, offered a different interpretation of public health data in a May 2026 interview with WBUR. According to Gruber, emergency room visits related to cannabis have increased, but "the vast majority involve edibles and concentrates consumed by tourists or inexperienced users, not regular consumers," and "there's no evidence that repeal would reduce these incidents—it would just push consumption back to unregulated products with unknown potency." Paul Armentano, deputy director of NORML, said in a June 9, 2026, statement that the rollback campaigns represent "a well-funded attempt to overturn the will of voters and restore a failed prohibition policy that disproportionately harmed communities of color." According to Armentano, the campaigns' focus on public health concerns "ignores the reality that prohibition creates far greater harms than regulation" by funding criminal organizations and exposing consumers to unregulated products.

What's Next

The rollback measures face legal challenges through summer 2026, with court decisions on signature validity expected by September, followed by intensive campaign periods leading to November 5, 2026, ballot decisions that could reshape the national cannabis reform landscape.

Legal Timeline

The Massachusetts lawsuit challenging signature validity is scheduled for a hearing in Suffolk County Superior Court on July 18, 2026. Judge Michael Ricci